Is it time for nitrated fibrinogen to prove its worth as a risk marker for venous thromboembolism?
作者信息
Arcaro Alessia, Lepore Alessio, Davinelli Sergio, Scapagnini Giovanni, Giallauria Francesco, Ames Paul R J, Gentile Fabrizio
机构信息
Department of Medicine and Health Sciences "V. Tiberio," University of Molise, Campobasso, Italy.
Department of Translational Medical Sciences, Precision Medicine Unit, Federico II University of Naples, Naples, Italy.
出版信息
Blood Vessel Thromb Hemost. 2025 Jan 3;2(2):100042. doi: 10.1016/j.bvth.2024.100042. eCollection 2025 May.
Abstract
摘要
相似文献
1
Is it time for nitrated fibrinogen to prove its worth as a risk marker for venous thromboembolism?现在是让硝化纤维蛋白原证明其作为静脉血栓栓塞风险标志物价值的时候了吗？
Blood Vessel Thromb Hemost. 2025 Jan 3;2(2):100042. doi: 10.1016/j.bvth.2024.100042. eCollection 2025 May.
2
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
3
Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research.妊娠期和产褥期的血栓预防：一项系统评价和经济评估，以估算未来研究的价值。
Health Technol Assess. 2024 Mar;28(9):1-176. doi: 10.3310/DFWT3873.
4
GRACE: protocol for a UK, secondary care, multicentre, assessor-blinded randomised controlled trial with a non-inferiority comparison to evaluate graduated compression stockings as an adjunct to extended duration pharmacological thromboprophylaxis for venous thromboembolism prevention.GRACE：一项英国二级医疗多中心、评估者设盲的随机对照试验方案，采用非劣效性比较，以评估分级压力袜作为延长药物性血栓预防疗程的辅助手段用于预防静脉血栓栓塞。
BMJ Open. 2025 Jul 6;15(7):e095482. doi: 10.1136/bmjopen-2024-095482.
5
Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.首次特发性静脉血栓栓塞症治疗后静脉血栓栓塞症复发风险的预测：系统评价、预后模型与临床决策规则以及经济学评估
Health Technol Assess. 2016 Feb;20(12):i-xxxiii, 1-190. doi: 10.3310/hta20120.
6
The incidence of thromboembolism formation following the use of recombinant factor VIIa in patients suffering from blunt force trauma compared with penetrating trauma: a systematic review.钝性创伤患者与穿透性创伤患者使用重组凝血因子VIIa后血栓栓塞形成的发生率：一项系统评价
JBI Database System Rev Implement Rep. 2016 Mar;14(3):116-38. doi: 10.11124/JBISRIR-2016-2063.
7
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.皮下注射普通肝素用于静脉血栓栓塞症的初始治疗。
Cochrane Database Syst Rev. 2017 Feb 14;2(2):CD006771. doi: 10.1002/14651858.CD006771.pub3.
8
Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.普通肝素与低分子量肝素用于预防术后患者肝素诱导的血小板减少症的比较
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD007557. doi: 10.1002/14651858.CD007557.pub3.
9
Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.预防带隧道式中心静脉导管的儿科癌症患者发生静脉血栓栓塞事件的全身治疗。
Cochrane Database Syst Rev. 2013 Sep 11(9):CD009160. doi: 10.1002/14651858.CD009160.pub2.
10
Endovenous ablation for venous leg ulcers.静脉内消融治疗静脉性腿部溃疡。
Cochrane Database Syst Rev. 2023 Jul 27;7(7):CD009494. doi: 10.1002/14651858.CD009494.pub3.
本文引用的文献
1
Fibrinogen levels and clot properties identify patients who benefit from catheter-directed thrombolysis after DVT.纤维蛋白原水平和血栓特性可识别出哪些接受 DVT 后导管定向溶栓治疗的患者从中受益。
Blood Adv. 2024 Jun 11;8(11):2924-2932. doi: 10.1182/bloodadvances.2023012493.
2
Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review.纤维蛋白原翻译后修饰对血栓形成、血栓结构和纤维蛋白溶解的影响：系统评价。
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):554-569. doi: 10.1161/ATVBAHA.119.313626. Epub 2020 Jan 9.
3
Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial.超声加速导管直接溶栓与抗凝预防血栓形成后综合征（CAVA）：一项单盲、多中心、随机试验
Lancet Haematol. 2020 Jan;7(1):e40-e49. doi: 10.1016/S2352-3026(19)30209-1. Epub 2019 Nov 27.
4
Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP).过氧亚硝酸盐诱导的DNA损伤在人类疾病中的病理生理作用：特别关注聚（ADP-核糖）聚合酶（PARP）
Indian J Clin Biochem. 2015 Oct;30(4):368-85. doi: 10.1007/s12291-014-0475-8. Epub 2015 Jan 20.
5
Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism.硝化纤维蛋白原是静脉血栓栓塞氧化应激的生物标志物。
Free Radic Biol Med. 2012 Jul 15;53(2):230-6. doi: 10.1016/j.freeradbiomed.2012.05.004. Epub 2012 May 10.
6
Sensitive immunoassays of nitrated fibrinogen in human biofluids.人生物液中硝化纤维蛋白的敏感免疫分析。
Talanta. 2010 Jun 15;81(4-5):1662-9. doi: 10.1016/j.talanta.2010.03.022. Epub 2010 Mar 19.
7
Peroxynitrite is the major species formed from different flux ratios of co-generated nitric oxide and superoxide: direct reaction with boronate-based fluorescent probe.过氧亚硝酸盐是由不同比例生成的一氧化氮和超氧化物共同作用形成的主要物种：与硼酸盐荧光探针的直接反应。
J Biol Chem. 2010 May 7;285(19):14210-6. doi: 10.1074/jbc.M110.110080. Epub 2010 Mar 1.
8
Quality control material for plasma fibrinogen test produced from purified human fibrinogen.由纯化的人纤维蛋白原制成的血浆纤维蛋白原检测用质控物质。
J Autom Methods Manag Chem. 2003;25(4):79-85. doi: 10.1155/S1463924603000142.
9
Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor.纤维蛋白原β链酪氨酸硝化是一种血栓形成前的危险因素。
J Biol Chem. 2008 Dec 5;283(49):33846-53. doi: 10.1074/jbc.M805522200. Epub 2008 Sep 25.
10
Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences.纤维蛋白原亚基对过氧亚硝酸根诱导的氧化/硝化修饰的不同敏感性：功能后果
Thromb Res. 2007;121(2):163-74. doi: 10.1016/j.thromres.2007.03.017. Epub 2007 Apr 27.
Zotero 插件